10-Q 1 ww-20240629.htm 10-Q 10-Q
--12-28false0000105319Q2http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNethttp://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNethttp://fasb.org/us-gaap/2024#OtherAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#OtherAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#AssetImpairmentChargeshttp://fasb.org/us-gaap/2024#AssetImpairmentChargeshttp://fasb.org/us-gaap/2024#AssetImpairmentChargeshttp://fasb.org/us-gaap/2024#AssetImpairmentChargeshttp://fasb.org/us-gaap/2024#PrepaidExpenseAndOtherAssetsCurrenthttp://fasb.org/us-gaap/2024#Assets0000105319ww:OtherCashRestructuringChargesMemberww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2022-01-022022-12-310000105319ww:OrganizationalRestructuringMemberww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:EmployeeTerminationBenefitCostsMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2024-06-290000105319us-gaap:FranchiseRightsMember2024-06-290000105319ww:OneMonthTermSecuredOvernightFinancingRateSofrMember2023-07-012023-07-010000105319ww:OtherMember2023-01-012023-07-010000105319ww:TermLoanFacilityDueAprilThirteenTwoThousandTwentyEightMember2024-06-290000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2022-01-022022-12-310000105319us-gaap:RevolvingCreditFacilityMemberww:FederalFundsEffectiveRateMember2023-12-312024-06-290000105319us-gaap:RelatedPartyMemberww:MsWinfreyAndHerRelatedEntitiesMember2024-06-290000105319ww:WeekendHealthIncDBASequenceMemberus-gaap:CommonStockMember2023-04-100000105319ww:LeaseTerminationCostsMemberww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2023-12-300000105319ww:LeaseTerminationCostsMemberww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2022-01-022022-12-310000105319ww:OtherCashRestructuringChargesMemberww:FiscalYearTwoThousandAndTwentyThreePlanMember2023-12-312024-06-290000105319us-gaap:TreasuryStockCommonMember2023-12-312024-06-290000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMemberww:EmployeeTerminationBenefitCostsMember2022-01-022022-12-310000105319us-gaap:FranchiseRightsMembercountry:US2023-12-312024-03-300000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:CumulativeAmountIncurredMember2022-04-032024-06-290000105319us-gaap:RetainedEarningsMember2022-12-310000105319ww:CreditFacilitiesAndSeniorSecuredNotesMember2024-06-290000105319us-gaap:CostOfSalesMemberww:FiscalYearTwoThousandAndTwentyThreePlanMember2022-01-022022-12-310000105319us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-300000105319ww:ThreeMonthTermSecuredOvernightFinancingRateSofrMember2023-07-012023-07-010000105319ww:SubscriptionMember2023-12-312024-06-290000105319ww:WeekendHealthIncDBASequenceMember2023-04-102023-04-100000105319ww:TwoThousandEighteenSwapMemberus-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2021-03-312021-03-310000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2024-06-290000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMemberww:EmployeeTerminationBenefitCostsMember2024-03-312024-06-2900001053192023-04-022023-07-010000105319ww:TwelveMonthTermSecuredOvernightFinancingRateSofrMember2023-07-012023-07-010000105319ww:FourPointFiveZeroZeroPercentSeniorSecuredNotesDue2029Member2021-07-030000105319us-gaap:CommonStockMember2023-12-300000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMember2023-01-012023-12-300000105319us-gaap:ForeignCountryMember2023-12-312024-06-290000105319us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-312024-06-290000105319country:GBus-gaap:FranchiseRightsMember2023-12-312024-03-300000105319us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-300000105319ww:TwoThousandAndTwentyFourRestructuringPlanMembersrt:MinimumMemberus-gaap:SubsequentEventMemberww:EmployeeTerminationBenefitCostsMember2024-07-272024-07-270000105319ww:CreditFacilitiesMember2024-06-290000105319us-gaap:RelatedPartyMemberww:MsWinfreyAndHerRelatedEntitiesMember2023-12-300000105319ww:ChangeOfControlMemberww:SeniorSecuredNotesDueAprilFifteenTwoThousandTwentyNineMember2023-12-312024-06-290000105319us-gaap:RetainedEarningsMember2024-06-290000105319ww:DigitalSubscriptionRevenuesMember2023-01-012023-07-010000105319us-gaap:RetainedEarningsMember2023-04-010000105319ww:OtherRevenuesNetMember2023-12-312024-06-290000105319us-gaap:FranchiseRightsMembercountry:US2024-06-290000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2024-06-290000105319ww:SeniorSecuredNotesDueAprilFifteenTwoThousandTwentyNineMember2023-12-300000105319ww:LeaseImpairmentMemberww:FiscalYearTwoThousandAndTwentyTwoPlanMember2022-01-022022-12-310000105319us-gaap:InterestExpenseMemberus-gaap:InterestRateContractMember2023-01-012023-07-010000105319ww:OtherCashRestructuringChargesMemberww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:CumulativeAmountIncurredMember2023-01-012024-06-290000105319us-gaap:RelatedPartyMemberww:MsWinfreyAndHerRelatedEntitiesMember2023-12-312024-06-290000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMember2024-03-312024-06-290000105319ww:OtherCashRestructuringChargesMemberww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2024-06-290000105319us-gaap:TreasuryStockCommonMember2024-03-312024-06-290000105319us-gaap:OperatingIncomeLossMemberus-gaap:InterestRateContractMember2023-04-022023-07-010000105319ww:LeaseTerminationCostsMemberww:FiscalYearTwoThousandAndTwentyTwoPlanMember2022-01-022022-12-310000105319ww:SubscriptionMember2023-04-022023-07-010000105319us-gaap:RelatedPartyMemberww:MsWinfreyAndHerRelatedEntitiesMember2023-01-012023-07-010000105319us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2023-12-300000105319us-gaap:CommonStockMember2023-01-012023-07-010000105319us-gaap:InterestRateContractMemberww:BenefitFromIncomeTaxesMember2023-04-022023-07-010000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberus-gaap:CostOfSalesMember2023-01-012023-12-300000105319ww:DigitalSubscriptionRevenuesMember2023-04-022023-07-010000105319ww:OtherRevenuesNetMember2024-03-312024-06-290000105319srt:MinimumMemberus-gaap:FranchiseRightsMembercountry:US2024-06-290000105319ww:FederalFundsEffectiveRateMemberww:TermLoanFacilityDueAprilThirteenTwoThousandTwentyEightMember2023-12-312024-06-290000105319ww:OtherCashRestructuringChargesMemberww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2022-12-310000105319ww:OrganizationalRestructuringMemberww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:CumulativeAmountIncurredMemberww:EmployeeTerminationBenefitCostsMember2022-10-022024-06-290000105319us-gaap:TreasuryStockCommonMember2023-04-022023-07-010000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:EmployeeTerminationBenefitCostsMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2022-01-022022-12-310000105319us-gaap:TreasuryStockCommonMember2024-06-290000105319us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-010000105319us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2022-12-310000105319us-gaap:FranchiseRightsMember2023-12-300000105319ww:OtherRevenuesNetMember2023-01-012023-07-010000105319us-gaap:LongTermContractWithCustomerMember2023-01-012023-07-010000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2023-01-012023-12-300000105319us-gaap:TrademarksMember2024-06-290000105319ww:OtherCashRestructuringChargesMemberww:FiscalYearTwoThousandAndTwentyThreePlanMember2023-01-012023-12-300000105319ww:ClinicalSubscriptionRevenuesMember2023-04-022023-07-010000105319us-gaap:CommonStockMember2022-12-310000105319us-gaap:RelatedPartyMemberww:MsWinfreyAndHerRelatedEntitiesMember2023-04-022023-07-010000105319us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-12-312024-06-290000105319ww:AcceleratedDepreciationAndAmortizationChargesMemberww:FiscalYearTwoThousandAndTwentyThreePlanMember2023-01-012023-12-300000105319ww:LeaseTerminationCostsMemberww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2023-12-312024-06-290000105319us-gaap:RevolvingCreditFacilityMembersrt:ScenarioForecastMember2025-03-302025-03-300000105319ww:OtherCashRestructuringChargesMemberww:FiscalYearTwoThousandAndTwentyTwoPlanMember2022-01-022022-12-310000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMemberww:EmployeeTerminationBenefitCostsMember2023-01-012023-12-300000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:EmployeeTerminationBenefitCostsMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2023-12-300000105319ww:TrademarksAndOtherIntangibleAssetsMember2024-06-290000105319srt:MaximumMemberus-gaap:FranchiseRightsMember2024-06-290000105319ww:OrganizationalRestructuringMemberww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:EmployeeTerminationBenefitCostsMember2023-01-012023-12-300000105319ww:LeaseTerminationCostsMemberww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2023-01-012023-12-300000105319ww:LeaseTerminationCostsMemberww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2023-01-012023-12-300000105319us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-300000105319us-gaap:TreasuryStockCommonMember2023-01-012023-07-0100001053192023-12-300000105319ww:SeniorSecuredRevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2021-04-130000105319us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberww:TermLoanFacilityDueAprilThirteenTwoThousandTwentyEightMember2023-12-312024-06-290000105319ww:SaleOfAssetsMemberww:SeniorSecuredNotesDueAprilFifteenTwoThousandTwentyNineMember2023-12-312024-06-290000105319us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2024-06-290000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMemberww:EmployeeTerminationBenefitCostsMember2023-12-312024-06-290000105319us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:RevolvingCreditFacilityMember2024-06-290000105319ww:LeaseTerminationCostsMemberww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMember2023-01-012023-12-300000105319srt:MaximumMember2023-12-312024-06-290000105319ww:SubscriptionMember2023-01-012023-07-010000105319us-gaap:InterestRateSwapMember2024-06-290000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2023-12-300000105319us-gaap:ShortTermContractWithCustomerMember2022-12-310000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberus-gaap:CostOfSalesMember2023-12-312024-06-290000105319ww:WeekendHealthIncDBASequenceMemberww:PurchasePriceAllocationMemberus-gaap:CommonStockMember2023-04-102023-04-100000105319ww:AllReportingUnitsExceptForRepublicOfIrelandMembersrt:MinimumMember2024-03-300000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:EmployeeTerminationBenefitCostsMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2023-01-012023-12-300000105319ww:CapitalizedSoftwareAndWebsiteDevelopmentCostsMember2024-06-290000105319ww:TwoThousandEighteenSwapMemberus-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2020-04-020000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-12-312024-06-290000105319ww:OtherCashRestructuringChargesMemberww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2023-12-300000105319us-gaap:CommonStockMember2024-03-300000105319us-gaap:ShortTermContractWithCustomerMember2023-12-300000105319us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberww:TermLoanFacilityDueAprilThirteenTwoThousandTwentyEightMember2024-06-290000105319us-gaap:ShortTermContractWithCustomerMember2023-07-010000105319us-gaap:LongTermContractWithCustomerMember2023-07-010000105319ww:TermLoanFacilityDueAprilThirteenTwoThousandTwentyEightMember2023-12-300000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:AcceleratedDepreciationAndAmortizationChargesMember2022-01-022022-12-310000105319us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-12-300000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2023-12-312024-06-290000105319ww:WeekendHealthIncDBASequenceMemberww:PurchasePriceAllocationMemberus-gaap:CommonStockMember2023-04-1000001053192024-06-290000105319ww:OrganizationalRestructuringMemberww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:EmployeeTerminationBenefitCostsMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2022-12-310000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:EmployeeTerminationBenefitCostsMember2022-01-022022-12-310000105319ww:NonCashRestructuringChargesMemberww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:CumulativeAmountIncurredMember2023-01-012024-06-290000105319us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-01-012023-07-010000105319us-gaap:LongTermContractWithCustomerMember2022-12-310000105319us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-312024-06-290000105319ww:TrademarksAndOtherIntangibleAssetsMember2023-12-300000105319ww:SixMonthTermSecuredOvernightFinancingRateSofrMember2023-07-012023-07-010000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:CumulativeAmountIncurredMember2022-10-022024-06-290000105319country:AUus-gaap:FranchiseRightsMember2023-12-312024-03-300000105319ww:OrganizationalRestructuringMemberww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMemberww:EmployeeTerminationBenefitCostsMember2023-01-012023-12-300000105319ww:ClinicalUnitMember2024-06-290000105319ww:OrganizationalRestructuringMemberww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:EmployeeTerminationBenefitCostsMember2024-03-312024-06-290000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMemberww:EmployeeTerminationBenefitCostsMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2022-12-310000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2022-12-310000105319ww:SeniorSecuredRevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2021-04-132021-04-130000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2022-12-3100001053192023-07-010000105319ww:OtherCashRestructuringChargesMemberww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2023-01-012023-12-300000105319ww:ClinicalSubscriptionRevenuesMember2023-12-312024-06-290000105319us-gaap:RevolvingCreditFacilityMember2023-12-300000105319us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-07-010000105319us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2023-12-300000105319ww:WeekendHealthIncDBASequenceMemberww:PurchasePriceAllocationMember2023-04-100000105319ww:CreditFacilitiesMember2021-07-030000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-12-300000105319us-gaap:TrademarksMember2023-12-300000105319us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-01-012023-07-010000105319us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-06-290000105319us-gaap:InterestRateContractMemberww:BenefitFromIncomeTaxesMember2023-01-012023-07-010000105319us-gaap:RevolvingCreditFacilityMember2024-06-290000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2023-12-3000001053192023-01-012023-12-300000105319ww:SeniorSecuredTrancheBTermLoanMemberww:TermLoanFacilityMember2021-04-130000105319us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-290000105319us-gaap:InterestExpenseMemberus-gaap:InterestRateContractMember2023-04-022023-07-0100001053192024-03-300000105319us-gaap:InterestExpenseMemberus-gaap:InterestRateContractMember2023-12-312024-06-290000105319us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-3100001053192024-03-302024-03-300000105319country:GBus-gaap:FranchiseRightsMember2024-06-290000105319ww:TwoThousandEighteenSwapMemberus-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2018-06-110000105319ww:DigitalSubscriptionRevenuesMember2023-12-312024-06-290000105319ww:IncomeLossBeforeIncomeTaxesMemberus-gaap:InterestRateContractMember2023-04-022023-07-010000105319us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-12-310000105319srt:MinimumMember2023-12-312024-06-290000105319us-gaap:ForeignCountryMember2024-03-312024-06-290000105319ww:LeaseTerminationCostsMemberww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMember2023-12-312024-06-290000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMember2022-01-022022-12-310000105319ww:WeekendHealthIncDBASequenceMemberus-gaap:CommonStockMember2023-04-102023-04-100000105319us-gaap:CostOfSalesMemberww:FiscalYearTwoThousandAndTwentyThreePlanMember2024-03-312024-06-290000105319country:NZus-gaap:FranchiseRightsMember2023-12-312024-03-300000105319ww:SubscriptionRevenuesNetMember2023-04-022023-07-010000105319ww:WorkshopsDigitalSubscriptionRevenuesMember2023-12-312024-06-290000105319ww:OthersNonCashRestructuringChargesMemberww:FiscalYearTwoThousandAndTwentyThreePlanMember2023-01-012023-12-300000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMemberww:EmployeeTerminationBenefitCostsMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2023-12-312024-06-290000105319us-gaap:RetainedEarningsMember2023-07-010000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2023-12-312024-06-290000105319ww:DigitalSubscriptionRevenuesMember2024-03-312024-06-290000105319ww:WeekendHealthIncDBASequenceMember2024-04-100000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMemberww:CumulativeAmountIncurredMemberww:EmployeeTerminationBenefitCostsMember2022-10-022024-06-290000105319ww:WeekendHealthIncDBASequenceMember2023-04-100000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2023-01-012023-12-300000105319us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2023-07-010000105319us-gaap:TreasuryStockCommonMember2023-04-010000105319ww:WeekendHealthIncDBASequenceMembersrt:ScenarioForecastMember2025-04-100000105319ww:WorkshopsDigitalSubscriptionRevenuesMember2023-01-012023-07-010000105319ww:TwoThousandEighteenSwapMemberus-gaap:InterestRateSwapMember2018-06-110000105319us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-12-300000105319ww:SeniorSecuredTrancheBTermLoanMemberww:TermLoanFacilityMember2021-04-132021-04-130000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-022022-12-310000105319ww:BehavioralReportingUnitMember2024-06-290000105319ww:WeekendHealthIncDBASequenceMemberww:PurchasePriceAllocationMember2024-04-100000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2024-03-312024-06-290000105319ww:WeekendHealthIncDBASequenceMember2023-04-022023-07-010000105319us-gaap:ShortTermContractWithCustomerMember2024-06-290000105319us-gaap:ShortTermContractWithCustomerMember2023-01-012023-07-010000105319us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-300000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-022022-12-310000105319us-gaap:CommonStockMember2023-04-0100001053192024-05-052024-05-050000105319us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-010000105319us-gaap:RevolvingCreditFacilityMember2023-12-312024-06-290000105319ww:ClinicalSubscriptionRevenuesMember2024-03-312024-06-290000105319us-gaap:RetainedEarningsMember2024-03-3000001053192023-05-072023-05-070000105319us-gaap:TreasuryStockCommonMember2024-03-300000105319srt:MinimumMembercountry:GBus-gaap:FranchiseRightsMember2024-06-290000105319ww:OtherMember2024-03-312024-06-290000105319us-gaap:RevolvingCreditFacilityMembersrt:ScenarioForecastMember2024-03-312025-03-290000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberus-gaap:CostOfSalesMember2022-01-022022-12-310000105319ww:OtherCashRestructuringChargesMemberww:FiscalYearTwoThousandAndTwentyThreePlanMember2024-03-312024-06-290000105319ww:WeekendHealthIncDBASequenceMemberww:PurchasePriceAllocationMembersrt:ScenarioForecastMember2025-04-100000105319ww:WorkshopsDigitalSubscriptionRevenuesMember2024-03-312024-06-290000105319us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-12-312024-06-290000105319us-gaap:InterestRateSwapMemberww:TwoThousandNineteenSwapMember2019-06-072019-06-070000105319us-gaap:CommonStockMember2023-04-022023-07-010000105319us-gaap:DebtInstrumentRedemptionPeriodThreeMemberww:SeniorSecuredNotesDueAprilFifteenTwoThousandTwentyNineMember2023-12-312024-06-290000105319ww:LeaseTerminationCostsMemberww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:CumulativeAmountIncurredMemberww:RealEstateRestructuringMember2023-01-012024-06-290000105319us-gaap:RetainedEarningsMember2024-03-312024-06-290000105319us-gaap:InterestRateContractMemberww:BenefitFromIncomeTaxesMember2023-12-312024-06-290000105319ww:SubscriptionRevenuesNetMember2023-01-012023-07-010000105319us-gaap:RetainedEarningsMember2023-12-300000105319ww:ClinicalSubscriptionRevenuesMember2023-01-012023-07-010000105319us-gaap:CommonStockMember2023-07-010000105319us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:RevolvingCreditFacilityMember2023-12-312024-06-290000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:EmployeeTerminationBenefitCostsMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2022-12-310000105319us-gaap:RetainedEarningsMember2023-04-022023-07-010000105319us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-022023-07-010000105319us-gaap:DebtInstrumentRedemptionPeriodTwoMemberww:SeniorSecuredNotesDueAprilFifteenTwoThousandTwentyNineMember2023-12-312024-06-290000105319us-gaap:InterestRateSwapMemberww:TwoThousandNineteenSwapMember2019-06-070000105319ww:IncomeLossBeforeIncomeTaxesMemberus-gaap:InterestRateContractMember2023-01-012023-07-010000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:OthersNonCashRestructuringChargesMember2022-01-022022-12-310000105319us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMemberww:TwoThousandNineteenSwapMember2019-06-070000105319ww:AllReportingUnitsExceptForRepublicOfIrelandMembersrt:MinimumMember2024-05-050000105319us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-07-0100001053192023-04-010000105319us-gaap:TreasuryStockCommonMember2022-12-310000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMember2023-12-312024-06-290000105319ww:OtherCashRestructuringChargesMemberww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2023-12-312024-06-2900001053192023-01-012023-07-010000105319ww:SeniorSecuredNotesDueAprilFifteenTwoThousandTwentyNineMember2024-06-290000105319us-gaap:OtherIntangibleAssetsMember2024-06-290000105319ww:WorkshopsDigitalSubscriptionRevenuesMember2023-04-022023-07-010000105319ww:SubscriptionMember2024-03-312024-06-290000105319ww:SubscriptionRevenuesNetMember2024-03-312024-06-290000105319ww:SubscriptionRevenuesNetMember2023-12-312024-06-290000105319us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberus-gaap:RevolvingCreditFacilityMembersrt:MaximumMember2023-12-312024-06-290000105319us-gaap:RetainedEarningsMember2023-01-012023-07-0100001053192024-07-250000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMemberww:EmployeeTerminationBenefitCostsMember2023-12-312024-06-290000105319ww:OtherMember2023-12-312024-06-290000105319us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-07-010000105319us-gaap:RetainedEarningsMember2023-12-312024-06-290000105319ww:OrganizationalRestructuringMemberww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:EmployeeTerminationBenefitCostsMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2023-12-312024-06-290000105319us-gaap:DebtInstrumentRedemptionPeriodOneMemberww:SeniorSecuredNotesDueAprilFifteenTwoThousandTwentyNineMember2023-12-312024-06-290000105319us-gaap:OperatingIncomeLossMemberus-gaap:InterestRateContractMember2023-01-012023-07-010000105319ww:OrganizationalRestructuringMemberww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:EmployeeTerminationBenefitCostsMember2022-01-022022-12-310000105319us-gaap:TreasuryStockCommonMember2023-07-010000105319ww:TwoThousandEighteenSwapMemberus-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2020-04-022020-04-020000105319us-gaap:LongTermContractWithCustomerMember2024-06-290000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMemberww:CashRestructuringRelatedLiabilitiesRollForwardMemberww:EmployeeTerminationBenefitCostsMember2024-06-290000105319ww:TwoThousandAndTwentyFourRestructuringPlanMemberus-gaap:SubsequentEventMembersrt:MaximumMemberww:EmployeeTerminationBenefitCostsMember2024-07-272024-07-270000105319us-gaap:FranchiseRightsMember2023-05-072023-05-070000105319ww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:EmployeeTerminationBenefitCostsMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2024-06-290000105319us-gaap:FranchiseRightsMember2024-05-052024-05-050000105319ww:WeekendHealthIncDBASequenceMemberww:PurchasePriceAllocationMember2023-04-102023-04-100000105319ww:OtherCashRestructuringChargesMemberww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2023-01-012023-12-300000105319ww:CapitalizedSoftwareAndWebsiteDevelopmentCostsMember2023-12-300000105319us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberww:TermLoanFacilityDueAprilThirteenTwoThousandTwentyEightMembersrt:MaximumMember2023-12-312024-06-290000105319ww:OrganizationalRestructuringMemberww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:EmployeeTerminationBenefitCostsMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2023-12-300000105319us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2024-06-290000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMember2022-01-022022-12-310000105319ww:OrganizationalRestructuringMemberww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:EmployeeTerminationBenefitCostsMember2023-12-312024-06-290000105319us-gaap:LongTermContractWithCustomerMember2023-12-300000105319ww:OtherRevenuesNetMember2023-04-022023-07-0100001053192022-12-310000105319ww:WeekendHealthIncDBASequenceMember2023-01-012023-07-010000105319ww:SeniorSecuredNotesDueAprilFifteenTwoThousandTwentyNineMember2023-12-312024-06-290000105319ww:TwoThousandEighteenSwapMemberus-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2021-03-310000105319us-gaap:OperatingIncomeLossMemberus-gaap:InterestRateContractMember2023-12-312024-06-290000105319ww:IncomeLossBeforeIncomeTaxesMemberus-gaap:InterestRateContractMember2023-12-312024-06-290000105319ww:TwoThousandEighteenSwapMemberus-gaap:InterestRateSwapMember2018-06-112018-06-110000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMemberww:EmployeeTerminationBenefitCostsMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2023-01-012023-12-300000105319us-gaap:OtherIntangibleAssetsMember2023-12-300000105319ww:OrganizationForEconomicCooperationAndDevelopmentGlobalTaxReformInitiativeMember2023-12-312024-06-2900001053192024-03-312024-06-290000105319us-gaap:TreasuryStockCommonMember2023-12-300000105319us-gaap:InterestRateSwapMember2023-12-300000105319us-gaap:LongTermContractWithCustomerMember2023-12-312024-06-290000105319us-gaap:CommonStockMember2024-06-2900001053192023-12-312024-06-290000105319ww:OtherMember2023-04-022023-07-010000105319us-gaap:ShortTermContractWithCustomerMember2023-12-312024-06-290000105319ww:FiscalYearTwoThousandAndTwentyThreePlanMemberww:RealEstateRestructuringMemberww:CashRestructuringRelatedLiabilitiesRollForwardMemberww:EmployeeTerminationBenefitCostsMember2023-12-3000001053192015-10-182015-10-180000105319us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2022-12-310000105319ww:LeaseTerminationCostsMemberww:FiscalYearTwoThousandAndTwentyTwoPlanMemberww:CashRestructuringRelatedLiabilitiesRollForwardMember2022-12-310000105319us-gaap:RelatedPartyMemberww:MsWinfreyAndHerRelatedEntitiesMember2024-03-312024-06-29xbrli:purexbrli:sharesww:Segmentiso4217:USDiso4217:USDxbrli:shares

 

Me

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 29, 2024

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-16769

 

WW INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

 

Virginia

 

11-6040273

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

675 Avenue of the Americas, 6th Floor, New York, New York 10010

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (212) 589-2700

 

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, no par value

WW

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

 

Accelerated filer

 

 

 

 

 

 

 

Non-accelerated filer

 

Smaller reporting company

 

 

 

 

 

 

 

 

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

 

The number of shares of common stock outstanding as of July 25, 2024 was 79,731,946.

 

 


 

 

WW INTERNATIONAL, INC.

TABLE OF CONTENTS

 

 

Page No.

 

 

 

PART I—FINANCIAL INFORMATION

 

 

 

 

Item 1.

Financial Statements

2

 

 

 

Unaudited Consolidated Balance Sheets at June 29, 2024 and December 30, 2023

2

 

 

 

Unaudited Consolidated Statements of Operations for the three and six months ended June 29, 2024 and July 1, 2023

3

 

 

 

Unaudited Consolidated Statements of Comprehensive Income (Loss) for the three and six months ended June 29, 2024 and July 1, 2023

4

 

 

 

 

Unaudited Consolidated Statements of Changes in Total Deficit for the three and six months ended June 29, 2024 and July 1, 2023

5

 

 

 

 

Unaudited Consolidated Statements of Cash Flows for the six months ended June 29, 2024 and July 1, 2023

6

 

 

 

Notes to Unaudited Consolidated Financial Statements

7

 

 

 

Cautionary Notice Regarding Forward-Looking Statements

25

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

27

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

48

 

 

 

Item 4.

Controls and Procedures

48

 

 

 

PART II—OTHER INFORMATION

 

 

 

 

Item 1.

Legal Proceedings

49

 

 

 

Item 1A.

Risk Factors

49

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

49

 

 

 

Item 3.

Defaults Upon Senior Securities

49

 

 

 

Item 4.

Mine Safety Disclosures

49

 

 

 

Item 5.

Other Information

49

 

 

 

Item 6.

Exhibits

50

 

 

 

Signatures

51

 

 


 

PART I—FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

WW INTERNATIONAL, INC. AND SUBSIDIARIES

UNAUDITED CONSOLIDATED BALANCE SHEETS AT

(IN THOUSANDS)

 

 

 

June 29,

 

 

December 30,

 

 

 

2024

 

 

2023

 

ASSETS

 

 

 

 

 

 

CURRENT ASSETS

 

 

 

 

 

 

Cash and cash equivalents

 

$

42,709

 

 

$

109,366

 

Receivables (net of allowances: June 29, 2024 - $2,025 and
   December 30, 2023 - $
1,041)

 

 

13,412

 

 

 

14,938

 

Prepaid income taxes

 

 

12,878

 

 

 

25,370

 

Prepaid marketing and advertising

 

 

1,898

 

 

 

10,149

 

Prepaid expenses and other current assets

 

 

17,194

 

 

 

19,651

 

TOTAL CURRENT ASSETS

 

 

88,091

 

 

 

179,474

 

Property and equipment, net

 

 

18,203

 

 

 

19,741

 

Operating lease assets

 

 

47,861

 

 

 

52,272

 

Franchise rights acquired

 

 

128,164

 

 

 

386,526

 

Goodwill

 

 

241,872

 

 

 

243,441

 

Other intangible assets, net

 

 

54,213

 

 

 

63,208

 

Deferred income taxes

 

 

16,615

 

 

 

19,683

 

Other noncurrent assets

 

 

19,237

 

 

 

17,685

 

TOTAL ASSETS

 

$

614,256

 

 

$

982,030

 

LIABILITIES AND TOTAL DEFICIT

 

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

 

 

Portion of operating lease liabilities due within one year

 

$

9,492

 

 

$

9,613

 

Accounts payable

 

 

25,119

 

 

 

18,507

 

Salaries and wages payable

 

 

40,434

 

 

 

79,096

 

Accrued marketing and advertising

 

 

14,028

 

 

 

18,215

 

Accrued interest

 

 

5,345

 

 

 

5,346

 

Deferred acquisition payable

 

 

14,608

 

 

 

16,500

 

Other accrued liabilities

 

 

22,122

 

 

 

22,610

 

Income taxes payable

 

 

35,373

 

 

 

1,609

 

Deferred revenue

 

 

33,849

 

 

 

33,966

 

TOTAL CURRENT LIABILITIES

 

 

200,370

 

 

 

205,462

 

Long-term debt, net

 

 

1,428,553

 

 

 

1,426,464

 

Long-term operating lease liabilities

 

 

49,043

 

 

 

53,461

 

Deferred income taxes

 

 

21,933

 

 

 

41,994

 

Other

 

 

1,640

 

 

 

15,743

 

TOTAL LIABILITIES

 

 

1,701,539

 

 

 

1,743,124

 

TOTAL DEFICIT

 

 

 

 

 

 

Common stock, $0 par value; 1,000,000 shares authorized; 130,048 
   shares issued at June 29, 2024 and
130,048 shares issued at
   December 30, 2023

 

 

0

 

 

 

0

 

Treasury stock, at cost, 50,344 shares at June 29, 2024 and 50,859
   shares at December 30, 2023

 

 

(3,040,679

)

 

 

(3,064,628

)

Retained earnings

 

 

1,970,791

 

 

 

2,314,834

 

Accumulated other comprehensive loss

 

 

(17,395

)

 

 

(11,300

)

TOTAL DEFICIT

 

 

(1,087,283

)

 

 

(761,094

)

TOTAL LIABILITIES AND TOTAL DEFICIT

 

$

614,256

 

 

$

982,030

 

 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

2


 

WW INTERNATIONAL, INC. AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS

(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

 

 

Three Months Ended

 

 

Six Months Ended

 

 

June 29,

 

 

July 1,

 

 

June 29,

 

 

July 1,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Subscription revenues, net

$

199,956

 

 

$

212,140

 

 

$

404,012

 

 

$

423,172

 

Other revenues, net

 

2,117

 

 

 

14,690

 

 

 

4,609

 

 

 

45,552

 

Revenues, net

 

202,073

 

 

 

226,830

 

 

 

408,621

 

 

 

468,724

 

Cost of subscription revenues

 

64,023

 

 

 

71,378

 

 

 

131,839

 

 

 

166,275

 

Cost of other revenues

 

756

 

 

 

12,272

 

 

 

1,688

 

 

 

39,758

 

Cost of revenues

 

64,779

 

 

 

83,650

 

 

 

133,527

 

 

 

206,033

 

Gross profit

 

137,294

 

 

 

143,180

 

 

 

275,094

 

 

 

262,691

 

Marketing expenses

 

53,696

 

 

 

51,119

 

 

 

143,858

 

 

 

139,353

 

Selling, general and administrative expenses

 

47,665

 

 

 

65,744

 

 

 

106,647

 

 

 

125,604

 

Franchise rights acquired impairments

 

 

 

 

 

 

 

257,988

 

 

 

 

Operating income (loss)

 

35,933

 

 

 

26,317

 

 

 

(233,399

)

 

 

(2,266

)

Interest expense

 

28,577

 

 

 

24,075

 

 

 

53,304

 

 

 

46,921

 

Other income, net

 

(78

)

 

 

(520

)

 

 

(1,683

)

 

 

(851

)

Income (loss) before income taxes

 

7,434

 

 

 

2,762

 

 

 

(285,020

)

 

 

(48,336

)

(Benefit from) provision for income taxes

 

(15,835

)

 

 

(48,066

)

 

 

39,613

 

 

 

19,515

 

Net income (loss)

$

23,269

 

 

$

50,828

 

 

$

(324,633

)

 

$

(67,851

)

Earnings (net loss) per share

 

 

 

 

 

 

 

 

 

 

 

Basic

$

0.29

 

 

$

0.65

 

 

$

(4.09

)

 

$

(0.91

)

Diluted

$

0.29

 

 

$

0.65

 

 

$

(4.09

)

 

$

(0.91

)

Weighted average common shares outstanding

 

 

 

 

 

 

 

 

 

 

 

Basic

 

79,483

 

 

 

78,007

 

 

 

79,345

 

 

 

74,302

 

Diluted

 

79,825

 

 

 

78,591

 

 

 

79,345

 

 

 

74,302

 

 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

3


 

WW INTERNATIONAL, INC. AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(IN THOUSANDS)

 

 

Three Months Ended

 

 

Six Months Ended

 

 

June 29,

 

 

July 1,

 

 

June 29,

 

 

July 1,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Net income (loss)

$

23,269

 

 

$

50,828

 

 

$

(324,633

)

 

$

(67,851

)

Other comprehensive (loss) gain:

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation (loss) gain

 

(616

)

 

 

816

 

 

 

(4,504

)

 

 

929

 

Income tax benefit (expense) on foreign currency translation (loss) gain

 

140

 

 

 

(204

)

 

 

1,125

 

 

 

(232

)

   Foreign currency translation (loss) gain, net of taxes

 

(476

)

 

 

612

 

 

 

(3,379

)

 

 

697

 

Loss on derivatives

 

 

 

 

(544

)

 

 

(3,473

)

 

 

(3,674

)

Income tax benefit on loss on derivatives

 

 

 

 

136

 

 

 

757

 

 

 

918

 

   Loss on derivatives, net of taxes

 

 

 

 

(408

)

 

 

(2,716

)

 

 

(2,756

)

Total other comprehensive (loss) gain

 

(476

)

 

 

204

 

 

 

(6,095

)

 

 

(2,059

)

Comprehensive income (loss)

$

22,793

 

 

$

51,032

 

 

$

(330,728

)

 

$

(69,910

)

 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

4


 

WW INTERNATIONAL, INC. AND SUBSIDIARIES

UNAUDITED Consolidated Statements of Changes in Total Deficit

(IN THOUSANDS)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Three Months Ended June 29, 2024

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Treasury Stock

 

 

Comprehensive

 

 

Retained

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Loss

 

 

Earnings

 

 

Total

 

Balance at March 30, 2024

 

 

130,048

 

 

$

0

 

 

 

50,803

 

 

$

(3,062,005

)

 

$

(16,919

)

 

$

1,966,625

 

 

$

(1,112,299

)

Comprehensive income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(476

)

 

 

23,269

 

 

 

22,793

 

Issuance of treasury stock under stock plans

 

 

 

 

 

 

 

 

(459

)

 

 

21,326

 

 

 

 

 

 

(21,843

)

 

 

(517

)

Compensation expense on share-based awards

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,740

 

 

 

2,740

 

Balance at June 29, 2024

 

 

130,048

 

 

$

0

 

 

 

50,344

 

 

$

(3,040,679

)

 

$

(17,395

)

 

$

1,970,791

 

 

$

(1,087,283

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended June 29, 2024

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Treasury Stock

 

 

Comprehensive

 

 

Retained

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Loss

 

 

Earnings

 

 

Total

 

Balance at December 30, 2023

 

 

130,048

 

 

$

0

 

 

 

50,859

 

 

$

(3,064,628

)

 

$

(11,300

)

 

$

2,314,834

 

 

$

(761,094

)

Comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(6,095

)

 

 

(324,633

)

 

 

(330,728

)

Issuance of treasury stock under stock plans

 

 

 

 

 

 

 

 

(515

)

 

 

23,949

 

 

 

 

 

 

(24,551

)

 

 

(602

)

Compensation expense on share-based awards

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5,141

 

 

 

5,141

 

Balance at June 29, 2024

 

 

130,048

 

 

$

0

 

 

 

50,344

 

 

$

(3,040,679

)

 

$

(17,395

)

 

$

1,970,791

 

 

$

(1,087,283

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Three Months Ended July 1, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Treasury Stock

 

 

Comprehensive

 

 

Retained

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Loss

 

 

Earnings

 

 

Total

 

Balance at April 1, 2023

 

 

122,052

 

 

$

0

 

 

 

51,418

 

 

$

(3,093,237

)

 

$

(7,733

)

 

$

2,298,701

 

 

$

(802,269

)

Comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

204

 

 

 

50,828

 

 

 

51,032

 

Issuance of treasury stock under stock plans

 

 

 

 

 

 

 

 

(272

)

 

 

14,164

 

 

 

 

 

 

(15,195

)

 

 

(1,031

)

Compensation expense on share-based awards

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,063

 

 

 

3,063

 

Issuance of common stock

 

 

7,996

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

32,943

 

 

 

32,943

 

Balance at July 1, 2023

 

 

130,048

 

 

$

0

 

 

 

51,146

 

 

$

(3,079,073

)

 

$

(7,529

)

 

$

2,370,340

 

 

$

(716,262

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended July 1, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other

 

 

 

 

 

 

 

 

 

Common Stock

 

 

Treasury Stock

 

 

Comprehensive

 

 

Retained

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Loss

 

 

Earnings

 

 

Total

 

Balance at December 31, 2022

 

 

122,052

 

 

$

0

 

 

 

51,496

 

 

$

(3,097,304

)

 

$

(5,470

)

 

$

2,418,959

 

 

$

(683,815

)

Comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2,059

)

 

 

(67,851

)

 

 

(69,910

)

Issuance of treasury stock under stock plans

 

 

 

 

 

 

 

 

(350

)

 

 

18,231

 

 

 

 

 

 

(19,442

)

 

 

(1,211

)

Compensation expense on share-based awards

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5,731

 

 

 

5,731

 

Issuance of common stock

 

 

7,996

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

32,943

 

 

 

32,943

 

Balance at July 1, 2023

 

 

130,048

 

 

$

0

 

 

 

51,146

 

 

$

(3,079,073

)

 

$

(7,529

)

 

$

2,370,340

 

 

$

(716,262

)

 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

5


 

WW INTERNATIONAL, INC. AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

(IN THOUSANDS)

 

 

 

Six Months Ended

 

 

 

June 29,

 

 

July 1,

 

 

 

2024

 

 

2023

 

Operating activities:

 

 

 

 

 

 

Net loss

 

$

(324,633

)

 

$

(67,851

)

Adjustments to reconcile net loss to cash used for operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

19,948

 

 

 

24,869

 

Amortization of deferred financing costs and debt discount

 

 

2,509

 

 

 

2,509

 

Impairment of franchise rights acquired

 

 

257,988

 

 

 

 

Impairment of intangible and long-lived assets

 

 

197

 

 

 

189

 

Share-based compensation expense

 

 

5,141

 

 

 

9,613

 

Deferred tax benefit

 

 

(14,948

)

 

 

(5,824

)

Allowance for doubtful accounts

 

 

6,886

 

 

 

(143

)

Reserve for inventory obsolescence

 

 

134

 

 

 

3,153

 

Foreign currency exchange rate gain

 

 

(1,249

)

 

 

(841

)

Changes in cash due to:

 

 

 

 

 

 

Receivables

 

 

3,407

 

 

 

57

 

Inventories

 

 

30

 

 

 

6,886

 

Prepaid expenses

 

 

18,956

 

 

 

10,321

 

Accounts payable

 

 

6,598

 

 

 

3,402

 

Accrued liabilities

 

 

(36,825

)

 

 

(19,536

)

Deferred revenue

 

 

142

 

 

 

1,975

 

Other long term assets and liabilities, net

 

 

(16,076

)

 

 

(1,265

)

Income taxes

 

 

33,819

 

 

 

5,429

 

Cash used for operating activities

 

 

(37,976

)

 

 

(27,057

)

Investing activities:

 

 

 

 

 

 

Capital expenditures

 

 

(730

)

 

 

(1,746

)

Capitalized software and website development expenditures

 

 

(9,376

)

 

 

(17,907

)

Cash paid for acquisitions, net of cash acquired

 

 

 

 

 

(38,362

)

Other items, net

 

 

(5

)

 

 

(8

)

Cash used for investing activities

 

 

(10,111

)

 

 

(58,023

)

Financing activities:

 

 

 

 

 

 

Taxes paid related to net share settlement of equity awards

 

 

(629

)

 

 

(1,319

)

Proceeds from stock options exercised

 

 

 

 

 

82

 

Cash paid for acquisitions

 

 

(16,500

)

 

 

(1,066

)

Other items, net

 

 

(3

)

 

 

(38

)

Cash used for financing activities

 

 

(17,132

)

 

 

(2,341

)

Effect of exchange rate changes on cash and cash equivalents

 

 

(1,438

)

 

 

541

 

Net decrease in cash and cash equivalents

 

 

(66,657

)

 

 

(86,880

)

Cash and cash equivalents, beginning of period

 

 

109,366

 

 

 

178,326

 

Cash and cash equivalents, end of period

 

$

42,709

 

 

$

91,446

 

 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

6


 

WW INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(IN THOUSANDS, EXCEPT PER SHARE AND PER UNIT AMOUNTS)

1.
Basis of Presentation

The accompanying consolidated financial statements include the accounts of WW International, Inc., all of its subsidiaries and the variable interest entities of which WW International, Inc. is the primary beneficiary. The terms “Company” and “WW” as used throughout these notes are used to indicate WW International, Inc. and all of its operations consolidated for purposes of its financial statements. The Company’s “Digital” business refers to providing subscriptions to the Company’s digital product offerings. The Company’s “Workshops + Digital” business refers to providing subscriptions for unlimited access to the Company’s workshops combined with the Company’s digital subscription product offerings. The Company’s “Clinical” business refers to providing subscriptions to the Company’s clinical product offerings provided by WeightWatchers Clinic (formerly referred to as Sequence).

The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and include amounts that are based on management’s best estimates and assumptions. While all available information has been considered, actual amounts could differ from those estimates. These estimates and assumptions may change as new events occur and additional information is obtained, and such future changes may have an adverse impact on the Company's results of operations, financial position and liquidity. The consolidated financial statements include all of the Company’s majority-owned subsidiaries. All entities acquired, and any entity of which a majority interest was acquired, are included in the consolidated financial statements from the date of acquisition. All intercompany accounts and transactions have been eliminated in consolidation. The Company’s operating results for any interim period are not necessarily indicative of future or annual results. The consolidated financial statements are unaudited and, accordingly, they do not include all of the information necessary for a comprehensive presentation of results of operations, financial position and cash flow activity required by GAAP for complete financial statements but, in the opinion of management, reflect all adjustments including those of a normal recurring nature necessary for a fair statement of the interim results presented.

As previously disclosed, effective the first day of fiscal 2024 (i.e., December 31, 2023), as a result of the continued evolution of the Company’s centralized organizational structure in fiscal 2023, and management’s 2024 strategic planning process, the Company’s reportable segments changed to one segment for the purpose of making operational and resource decisions and assessing financial performance. Since the Company operates in one operating segment and reportable segment, all required financial segment information can be found in the consolidated financial statements.

In the second quarter of fiscal 2024, the Company identified and recorded an out-of-period adjustment related to an income tax error. The impact of correcting this error, which was immaterial to all current and prior period financial statements and corrected in the second quarter of fiscal 2024, resulted in an income tax expense of approximately $2,900, with a corresponding decrease to net income, for the three months ended June 29, 2024.

These consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for fiscal 2023 filed on February 28, 2024, which includes additional information about the Company, its results of operations, its financial position and its cash flows.

2.
Accounting Standards Adopted in Current Year

There were no new accounting standards adopted during the six months ended June 29, 2024.

 

7


WW INTERNATIONAL, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

(IN THOUSANDS, EXCEPT PER SHARE AND PER UNIT AMOUNTS)

 

3.
Leases

At June 29, 2024 and December 30, 2023, the Company’s lease assets and lease liabilities, primarily for its studios and corporate offices, were as follows:

 

 

 

June 29, 2024

 

 

December 30, 2023

 

Assets:

 

 

 

 

 

 

Operating leases

 

$

47,861

 

 

$

52,272

 

Finance leases

 

 

1

 

 

 

5

 

Total lease assets

 

$

47,862

 

 

$

52,277

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

Current

 

 

 

 

 

 

Operating leases

 

$

9,492

 

 

$

9,613

 

Finance leases

 

 

1

 

 

 

4

 

Noncurrent

 

 

 

 

 

 

Operating leases

 

 

49,043

 

 

 

53,461

 

Finance leases

 

 

 

 

 

 

Total lease liabilities

 

$

58,536